A study published this week in The Journals of Gerontology Series A reports that accelerated biological aging in monocytes — a class of white blood cells — correlates with the cognitive and mood symptoms of major depression but not with the physical symptoms. [1] Hopelessness and anhedonia track the monocyte-aging signal. Fatigue does not. The finding suggests a measurable peripheral marker for what psychiatrists call the cognitive cluster, and a different biology underneath the somatic cluster.

The cohort is 440 women — 261 with HIV, 179 without. [2] Biological age was estimated using epigenetic clocks calibrated to monocytes specifically, rather than the more common whole-blood DNA-methylation clocks. The HIV inclusion is not incidental: women living with HIV experience accelerated immune aging and elevated rates of depression, and the study's design uses that gradient to test whether the immune-aging signal tracks symptoms or merely tracks HIV status. The signal tracks symptoms.

What the study does not do is propose a clinical test. The cohort is small, single-sex, and biased toward an inflammatory comorbidity. The principle, however, is the news. [3] If cognitive depression has a peripheral immune signature and somatic depression does not, the long-running argument that the DSM's major depressive disorder lumps biologically distinct diseases gains a measurable handle. That handle is what a blood test would eventually be built on. It would not be a test for "depression." It would be a test for the cognitive subtype — the one that responds differently to treatment, predicts cognitive decline, and now appears to have a different cell biology.

-- KENJI NAKAMURA, Tokyo